SG83147A1 - Polymorph of zopolrestat monohydrate - Google Patents

Polymorph of zopolrestat monohydrate

Info

Publication number
SG83147A1
SG83147A1 SG9904131A SG1999004131A SG83147A1 SG 83147 A1 SG83147 A1 SG 83147A1 SG 9904131 A SG9904131 A SG 9904131A SG 1999004131 A SG1999004131 A SG 1999004131A SG 83147 A1 SG83147 A1 SG 83147A1
Authority
SG
Singapore
Prior art keywords
polymorph
zopolrestat monohydrate
zopolrestat
monohydrate
Prior art date
Application number
SG9904131A
Other languages
English (en)
Inventor
Francis Lambert John
Norris Timothy
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SG83147A1 publication Critical patent/SG83147A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
SG9904131A 1998-08-21 1999-08-19 Polymorph of zopolrestat monohydrate SG83147A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9747498P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
SG83147A1 true SG83147A1 (en) 2001-09-18

Family

ID=22263562

Family Applications (1)

Application Number Title Priority Date Filing Date
SG9904131A SG83147A1 (en) 1998-08-21 1999-08-19 Polymorph of zopolrestat monohydrate

Country Status (31)

Country Link
US (1) US6159976A (no)
EP (1) EP0982306A3 (no)
JP (1) JP2000072769A (no)
KR (1) KR20000017411A (no)
CN (1) CN1245804A (no)
AP (1) AP9901662A0 (no)
AU (1) AU4453299A (no)
BG (1) BG103674A (no)
BR (1) BR9903873A (no)
CA (1) CA2280590A1 (no)
EA (1) EA199900675A3 (no)
EE (1) EE9900385A (no)
GT (1) GT199900137A (no)
HR (1) HRP990259A2 (no)
HU (1) HUP9902783A3 (no)
ID (1) ID23307A (no)
IL (1) IL131419A0 (no)
IS (1) IS5155A (no)
MA (1) MA26678A1 (no)
NO (1) NO994027L (no)
NZ (1) NZ337363A (no)
OA (1) OA11150A (no)
PA (1) PA8480601A1 (no)
PE (1) PE20000993A1 (no)
PL (1) PL335016A1 (no)
SG (1) SG83147A1 (no)
TN (1) TNSN99159A1 (no)
TR (1) TR199901996A2 (no)
UY (1) UY25668A1 (no)
YU (1) YU39899A (no)
ZA (1) ZA995297B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5934206B2 (ja) 2010-07-16 2016-06-15 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク アルドース還元酵素阻害剤および同使用方法
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
WO2014126885A1 (en) * 2013-02-13 2014-08-21 Mylari Banavara L Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
BR112018076244A2 (pt) 2016-06-21 2019-03-26 The Trustees Of Columbia University In The City Of New York inibidores da aldose redutase e métodos de uso destes
PL3658142T3 (pl) 2017-07-28 2024-08-26 Applied Therapeutics, Inc. Związki i sposoby leczenia galaktozemii
JP2022519944A (ja) 2019-04-01 2022-03-25 アプライド セラピューティクス インコーポレイテッド アルドースレダクターゼの阻害剤
SG11202111822QA (en) 2019-05-07 2021-11-29 Univ Miami Treatment and detection of inherited neuropathies and associated disorders
WO2021202523A1 (en) 2020-03-31 2021-10-07 Applied Therapeutics, Inc. Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy
WO2021222165A1 (en) 2020-05-01 2021-11-04 Applied Therapeutics, Inc. Aldose reductase inhibitors for treating sorbitol dehydrogenase deficiency

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295051A2 (en) * 1987-06-09 1988-12-14 Pfizer Inc. Preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
EP0624369A1 (en) * 1993-05-10 1994-11-17 Pfizer Inc. Method of lowering blood lipid levels
EP0792643A1 (en) * 1996-02-29 1997-09-03 Pfizer Inc. Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4748280A (en) * 1985-11-07 1988-05-31 Pfizer Inc. Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295051A2 (en) * 1987-06-09 1988-12-14 Pfizer Inc. Preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
EP0624369A1 (en) * 1993-05-10 1994-11-17 Pfizer Inc. Method of lowering blood lipid levels
EP0792643A1 (en) * 1996-02-29 1997-09-03 Pfizer Inc. Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage

Also Published As

Publication number Publication date
HU9902783D0 (en) 1999-10-28
TR199901996A2 (xx) 2000-03-21
NZ337363A (en) 2001-01-26
HUP9902783A2 (hu) 2000-12-28
BG103674A (en) 2000-03-31
PE20000993A1 (es) 2000-10-04
CA2280590A1 (en) 2000-02-21
MA26678A1 (fr) 2004-12-20
ID23307A (id) 2000-04-05
AU4453299A (en) 2000-03-09
IL131419A0 (en) 2001-01-28
NO994027D0 (no) 1999-08-20
BR9903873A (pt) 2000-09-19
HRP990259A2 (en) 2000-06-30
GT199900137A (es) 2001-02-09
US6159976A (en) 2000-12-12
EE9900385A (et) 2000-04-17
UY25668A1 (es) 2001-08-27
NO994027L (no) 2000-02-22
OA11150A (en) 2003-04-16
PA8480601A1 (es) 2000-09-29
EA199900675A2 (ru) 2000-02-28
HUP9902783A3 (en) 2001-01-29
AP9901662A0 (en) 1999-09-30
PL335016A1 (en) 2000-02-28
IS5155A (is) 2000-02-22
CN1245804A (zh) 2000-03-01
EP0982306A3 (en) 2000-07-05
EA199900675A3 (ru) 2000-06-26
EP0982306A2 (en) 2000-03-01
JP2000072769A (ja) 2000-03-07
ZA995297B (en) 2001-02-19
TNSN99159A1 (fr) 2005-11-10
YU39899A (sh) 2002-12-10
KR20000017411A (ko) 2000-03-25

Similar Documents

Publication Publication Date Title
PL341647A1 (en) Novel derivatives of erythromycin
PL339659A1 (en) Crystalline antimycotic polymorph
HK1034721A1 (en) Crystalline forms of eto2c-ch2-(r)cgl-aze-pab-oh
IL191582A0 (en) Polymorph of a pharmaceutical
PL342469A1 (en) Method of obtaining stilbenic compounds
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
AU1393799A (en) Cooling of stored water
HU9902783D0 (en) Polymorph of zopolrestat monohydrate
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
PL345542A1 (en) Novel salts of n-tert-butylhydroxylamine
IL142218A0 (en) PROCESS FOR THE PREPARATION OF (-) -α- DIFLUORMETHYLORNITHINE MONOHYDROCHLORIDE MONOHYDRATE
SI1107980T1 (en) CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH
TW475509U (en) Structure of tool set
PL336552A1 (en) Method of obtaining osmotherapeutic mixtures of anhydrohexithioles
TW366106U (en) Improved structure for assist-glasses of glasses
TW357888U (en) Improvement of filter-drier
TW360309U (en) Improved structure for column of expansion pulling-door
PL337598A1 (en) Novel compound - derivative of (r)-3-hydroxynonanal
PL331156A1 (en) Method of obtaining roxythromycin
GB9810855D0 (en) Use of compounds
TW369024U (en) Improved structure of drain head
TW370994U (en) Structure of convenient wall
TW410608U (en) Improved structure of nipple
TW376159U (en) Structure of glasses for sport
TW346160U (en) Improved structure for connection of expanding pipe